Intraoperative nodal staging. Role of sentinel node technology.

Shinichiro Miyoshi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In cases of superficial malignancies such as melanoma or breast cancer, intraoperative lymph node mapping with a sentinel lymph node (SLN) biopsy is an effective and minimally invasive alternative to inguinal or axillary lymph node dissection for early-stage tumors. For primary lung cancer, although much effort has been made to investigate a variety of tracers, such as dyes, radioisotopes, magnetite, and iopamidol, for discerning SLNs, an appropriate agent that produces high identification and accuracy rates has yet to be developed. Further studies are needed to find an ideal tracer for practical use in patients with non-small cell lung cancer.

Original languageEnglish
Pages (from-to)357-368
Number of pages12
JournalThoracic Surgery Clinics
Volume23
Issue number3
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Iopamidol
Ferrosoferric Oxide
Technology
Sentinel Lymph Node Biopsy
Groin
Lymph Node Excision
Non-Small Cell Lung Carcinoma
Radioisotopes
Melanoma
Lung Neoplasms
Neoplasms
Coloring Agents
Lymph Nodes
Breast Neoplasms
cyhalothrin

Keywords

  • Lung cancer
  • Lymphadenectomy
  • Radioisotope
  • Sentinel lymph node
  • Tracer

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Intraoperative nodal staging. Role of sentinel node technology. / Miyoshi, Shinichiro.

In: Thoracic Surgery Clinics, Vol. 23, No. 3, 08.2013, p. 357-368.

Research output: Contribution to journalArticle

Miyoshi, Shinichiro. / Intraoperative nodal staging. Role of sentinel node technology. In: Thoracic Surgery Clinics. 2013 ; Vol. 23, No. 3. pp. 357-368.
@article{79ca25430a3d4c7ea30f194437981077,
title = "Intraoperative nodal staging. Role of sentinel node technology.",
abstract = "In cases of superficial malignancies such as melanoma or breast cancer, intraoperative lymph node mapping with a sentinel lymph node (SLN) biopsy is an effective and minimally invasive alternative to inguinal or axillary lymph node dissection for early-stage tumors. For primary lung cancer, although much effort has been made to investigate a variety of tracers, such as dyes, radioisotopes, magnetite, and iopamidol, for discerning SLNs, an appropriate agent that produces high identification and accuracy rates has yet to be developed. Further studies are needed to find an ideal tracer for practical use in patients with non-small cell lung cancer.",
keywords = "Lung cancer, Lymphadenectomy, Radioisotope, Sentinel lymph node, Tracer",
author = "Shinichiro Miyoshi",
year = "2013",
month = "8",
doi = "10.1016/j.thorsurg.2013.04.002",
language = "English",
volume = "23",
pages = "357--368",
journal = "Thoracic Surgery Clinics",
issn = "1547-4127",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Intraoperative nodal staging. Role of sentinel node technology.

AU - Miyoshi, Shinichiro

PY - 2013/8

Y1 - 2013/8

N2 - In cases of superficial malignancies such as melanoma or breast cancer, intraoperative lymph node mapping with a sentinel lymph node (SLN) biopsy is an effective and minimally invasive alternative to inguinal or axillary lymph node dissection for early-stage tumors. For primary lung cancer, although much effort has been made to investigate a variety of tracers, such as dyes, radioisotopes, magnetite, and iopamidol, for discerning SLNs, an appropriate agent that produces high identification and accuracy rates has yet to be developed. Further studies are needed to find an ideal tracer for practical use in patients with non-small cell lung cancer.

AB - In cases of superficial malignancies such as melanoma or breast cancer, intraoperative lymph node mapping with a sentinel lymph node (SLN) biopsy is an effective and minimally invasive alternative to inguinal or axillary lymph node dissection for early-stage tumors. For primary lung cancer, although much effort has been made to investigate a variety of tracers, such as dyes, radioisotopes, magnetite, and iopamidol, for discerning SLNs, an appropriate agent that produces high identification and accuracy rates has yet to be developed. Further studies are needed to find an ideal tracer for practical use in patients with non-small cell lung cancer.

KW - Lung cancer

KW - Lymphadenectomy

KW - Radioisotope

KW - Sentinel lymph node

KW - Tracer

UR - http://www.scopus.com/inward/record.url?scp=84881377426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881377426&partnerID=8YFLogxK

U2 - 10.1016/j.thorsurg.2013.04.002

DO - 10.1016/j.thorsurg.2013.04.002

M3 - Article

C2 - 23931019

AN - SCOPUS:84881377426

VL - 23

SP - 357

EP - 368

JO - Thoracic Surgery Clinics

JF - Thoracic Surgery Clinics

SN - 1547-4127

IS - 3

ER -